Çizgi Teknoloji has been awarded one of a limited number of licenses to produce the NASA-JPL VITAL COVID-19 Ventilator.

Dear Business Partners,

As Çizgi Teknoloji, we have achieved many firsts and significant milestones throughout our 25-year journey in R&D and manufacturing. Today, we are proud to add another remarkable accomplishment to this journey.

Thanks to our advanced engineering capabilities, our expertise in industrial and medical device manufacturing, and our strong competency in innovative product development, we have been selected as the only Turkish company among the 28 organizations worldwide granted a production license for NASA’s VITAL ventilator. This recognition represents an important milestone not only for our company but also for our country’s technological vision.

For over 25 years, your trust and support in our pioneering solutions in automation, digital technologies, and healthcare systems have played a vital role in reaching this point. We extend our sincere gratitude to all our valued business partners. This achievement belongs to all of us.

Developed within just 37 days by NASA engineers at the Jet Propulsion Laboratory (Caltech) to meet the urgent global need for ventilators during the COVID-19 pandemic, the VITAL (Ventilator Intervention Technology Accessible Locally) device received FDA approval and became a critical solution for rapid, local manufacturing. Out of 331 global applicants, 100 companies were evaluated, and only 28 licenses were granted across six continents—including just nine in the United States. We are honored to represent Türkiye on this global stage.

At Çizgi Teknoloji, we remain committed to contributing to our country’s technological advancement and global competitiveness. Together with our business partners, we will continue to innovate, develop, and deliver solutions that create meaningful value.

For more information; https://medeng.jpl.nasa.gov/covid-19/ventilator/registration/